Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Med Chem. 2014 Jan 24;72:102-9. doi: 10.1016/j.ejmech.2013.11.021. Epub 2013 Dec 1.

A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation.

Author information

  • 1CNR, Institute of Clinical Physiology, Via G. Moruzzi, 1, 56124 Pisa, Italy.
  • 2Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.
  • 3Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy. Electronic address: concettina.lamotta@farm.unipi.it.
  • 4CNR, Institute of Clinical Physiology, Via G. Moruzzi, 1, 56124 Pisa, Italy. Electronic address: lapina@ifc.cnr.it.

Abstract

Hyper-proliferation and migration of vascular smooth muscle cells and endothelial cell dysfunction are central events in the development of neo-intimal lesions. Pursuing our interest in the synthesis of bioisosters of flavonoids, we studied in depth a novel synthetic 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative, examining its effects in vitro on induced-cell proliferation and activation in human aortic smooth muscle cells (HAoSMCs) and in human umbilical vein endothelial cells (HUVECs). Compared with two well known flavonoids, apigenin and quercetin, the novel compound, 2-(3,4-dimethoxyphenyl)-3-phenyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3, was not toxic for HUVECs, even at high concentrations and for long incubation times, while the two flavonoids were not tolerated, even at concentrations as low as 10 μmol/L. Compound 3 inhibited selectively, and in a concentration-dependent manner, the proliferation of HAoSMCs but not that of HUVECs. In HUVECs, it inhibited the cytokine-induced vascular cell adhesion molecule-1 expression, but not the cyclooxygenase-2 (COX-2) expression. Instead, in HAoSMC, it inhibited the induction of COX-2 expression and the relative release of prostaglandin E2. In addition, it inhibited the transcription of the matrix metalloproteinase-9 and its activity. Thanks to its multiple and tissue-specific function, 2-(3,4-dimethoxyphenyl)-3-phenyl-4H-pyrido[1,2-a]pyrimidin-4-one might replace or assist the action of current drugs eluted by coronary stents, in order to promote a functional repair of damaged wall.

Copyright © 2013 Elsevier Masson SAS. All rights reserved.

KEYWORDS:

2,3-Diphenyl-4H-pyrido[1,2-a]pyrimidin-4-ones; 2-(3,4-Dimethoxyphenyl)-3-phenyl-4H-pyrido[1,2-a]pyrimidin-4-one; COX-2; Cell dysfunction; Cell proliferation; ECGF; HAoSMCs; HUVECs; Human aortic smooth muscle cells; Human umbilical vein endothelial cells; MMP-9; PDGF-BB; PGE(2); PGI(2); PMA; TNF-α; VCAM-1; cyclooxygenase-2; endothelial cell growth factor; human aortic smooth muscle cells; human umbilical vein endothelial cells; matrix metalloproteinase-9; phorbol 12-myristate 13-acetate; platelet derived growth factor-BB; prostacyclin; prostaglandin E(2); tumor necrosis factor-α; vascular cell adhesion molecule-1

PMID:
24361522
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk